D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 66 Citations 12,379 172 World Ranking 1281 National Ranking 104
Medicine D-index 88 Citations 28,907 392 World Ranking 6584 National Ranking 615

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

His primary areas of study are Drug resistance, Virology, Acquired immunodeficiency syndrome, Immunology and Internal medicine. His biological study spans a wide range of topics, including Bioinformatics, Transmission, HIV drug resistance and Pharmacology, Drug. His Virology research incorporates elements of Mutation, Genetics, Reverse transcriptase and Raltegravir.

The Acquired immunodeficiency syndrome study combines topics in areas such as Expanded access, Epidemiology and Intensive care medicine. His research in Internal medicine intersects with topics in Gastroenterology, Lamivudine, Sexually transmitted disease and Nevirapine. Deenan Pillay studied Viral load and Cohort study that intersect with Pharmacotherapy.

His most cited work include:

  • Update of the Drug Resistance Mutations in HIV-1. (1203 citations)
  • British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008 (1031 citations)
  • Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update (707 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Virology, Drug resistance, Immunology, Viral load and Acquired immunodeficiency syndrome. He focuses mostly in the field of Virology, narrowing it down to matters related to Reverse transcriptase and, in some cases, Mutation. His Drug resistance research incorporates elements of Transmission, HIV drug resistance, Resistance mutation, Genotype and Drug.

His studies examine the connections between Immunology and genetics, as well as such issues in Antiretroviral therapy, with regards to Intensive care medicine. His Viral load research includes elements of Regimen, Internal medicine, Pharmacotherapy, Lamivudine and Nevirapine. His Acquired immunodeficiency syndrome research is multidisciplinary, relying on both Demography and Environmental health.

He most often published in these fields:

  • Virology (43.88%)
  • Drug resistance (36.45%)
  • Immunology (30.70%)

What were the highlights of his more recent work (between 2016-2021)?

  • Demography (16.07%)
  • Public health (10.31%)
  • Viral load (28.78%)

In recent papers he was focusing on the following fields of study:

Deenan Pillay mainly investigates Demography, Public health, Viral load, Acquired immunodeficiency syndrome and Psychological intervention. His studies in Demography integrate themes in fields like Young adult, Incidence and Cohort. Deenan Pillay has included themes like Internal medicine, Interquartile range, Lamivudine and Nevirapine, Antiretroviral therapy in his Viral load study.

Deenan Pillay works mostly in the field of Internal medicine, limiting it down to topics relating to Emtricitabine and, in certain cases, Efavirenz, as a part of the same area of interest. His Acquired immunodeficiency syndrome study combines topics from a wide range of disciplines, such as Test, Drug resistance and Confidence interval. His Drug resistance research also works with subjects such as

  • Regimen that connect with fields like Dolutegravir,
  • Reverse transcriptase, which have a strong connection to Virology.

Between 2016 and 2021, his most popular works were:

  • Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. (196 citations)
  • HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis (166 citations)
  • Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial (120 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

Deenan Pillay mainly focuses on Demography, Public health, Drug resistance, Viral load and Acquired immunodeficiency syndrome. His Demography research integrates issues from Young adult, Incidence, Cross-sectional study and Reproductive health. Deenan Pillay combines subjects such as Regimen, Transmission, HIV drug resistance, Integrase and Efavirenz with his study of Drug resistance.

His Transmission research is included under the broader classification of Virology. Deenan Pillay interconnects Internal medicine, Lamivudine, Antiretroviral therapy, Pediatrics and Population health in the investigation of issues within Viral load. His study focuses on the intersection of Acquired immunodeficiency syndrome and fields such as Confidence interval with connections in the field of Random effects model and Sequence analysis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Update of the Drug Resistance Mutations in HIV-1.

Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard.
Topics in HIV medicine : a publication of the International AIDS Society, USA (2008)

1940 Citations

2011 update of the drug resistance mutations in HIV-1.

V A Johnson;Calvez;H F Gunthard;R Paredes.
Topics in antiviral medicine (2011)

1225 Citations

British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

B G Gazzard;Jane Anderson;Abdel Babiker;Marta Boffito.
Hiv Medicine (2005)

1015 Citations

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

Diane E. Bennett;Ricardo J. Camacho;Dan Otelea;Daniel R. Kuritzkes.
PLOS ONE (2009)

992 Citations

2017 Update of the Drug Resistance Mutations in HIV-1.

Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson.
Topics in antiviral medicine (2016)

770 Citations

2015 Update of the Drug Resistance Mutations in HIV-1.

Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson.
Topics in antiviral medicine (2015)

758 Citations

2014 Update of the drug resistance mutations in HIV-1.

Annemarie M Wensing;Vincent Calvez;Huldrych F Günthard;Victoria A Johnson.
Topics in antiviral medicine (2014)

757 Citations

Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Françoise Brun Vézinet.
Clinical Infectious Diseases (2008)

622 Citations

Update of the Drug Resistance Mutations in HIV-1: 2005.

Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway.
Topics in HIV medicine : a publication of the International AIDS Society, USA (2005)

505 Citations

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn.
Lancet Infectious Diseases (2011)

425 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Deenan Pillay

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 137

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 122

Anne-Mieke Vandamme

Anne-Mieke Vandamme

Rega Institute for Medical Research

Publications: 115

Carlo Federico Perno

Carlo Federico Perno

University of Milan

Publications: 103

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 101

Caroline Sabin

Caroline Sabin

University College London

Publications: 86

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 86

Anders Sönnerborg

Anders Sönnerborg

Karolinska Institute

Publications: 85

P. Richard Harrigan

P. Richard Harrigan

University of British Columbia

Publications: 81

Davey M. Smith

Davey M. Smith

University of California, San Diego

Publications: 80

Robert W. Shafer

Robert W. Shafer

Stanford University

Publications: 80

Vincent Soriano

Vincent Soriano

Hospital Universitario La Paz

Publications: 75

Sabine Yerly

Sabine Yerly

Geneva College

Publications: 74

Joseph J. Eron

Joseph J. Eron

University of North Carolina at Chapel Hill

Publications: 71

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 69

Till Bärnighausen

Till Bärnighausen

Harvard University

Publications: 69

Trending Scientists

Jehoshua Bruck

Jehoshua Bruck

California Institute of Technology

Juin J. Liou

Juin J. Liou

Shenzhen University

Freddy Adams

Freddy Adams

University of Antwerp

Hideki Masuda

Hideki Masuda

Nagoya Institute of Technology

Claude Miaud

Claude Miaud

University of Montpellier

Jonathan D. Blount

Jonathan D. Blount

University of Exeter

M. Alejandra Tortorici

M. Alejandra Tortorici

University of Washington

John Moult

John Moult

University of Maryland, College Park

Peter J. Bond

Peter J. Bond

Agency for Science, Technology and Research

Karl G. Nicholson

Karl G. Nicholson

University of Leicester

Stefania Stefani

Stefania Stefani

University of Catania

Frances M. Leslie

Frances M. Leslie

University of California, Irvine

Robert S. Sandler

Robert S. Sandler

University of North Carolina at Chapel Hill

Steven M. Kawut

Steven M. Kawut

University of Pennsylvania

Marleen Boelaert

Marleen Boelaert

Institute of Tropical Medicine Antwerp

James Thomas

James Thomas

University College London

Something went wrong. Please try again later.